David Michael Johnson - Net Worth and Insider Trading
David Michael Johnson Net Worth
The estimated net worth of David Michael Johnson is at least $4 Million dollars as of 2024-11-29. David Michael Johnson is the Director of Aura Biosciences Inc and owns about 425,339 shares of Aura Biosciences Inc (AURA) stock worth over $4 Million. David Michael Johnson is also the Director of Zentalis Pharmaceuticals Inc and owns about 144,389 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $524,132. Details can be seen in David Michael Johnson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Michael Johnson has not made any transactions after 2023-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Michael Johnson
David Michael Johnson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Michael Johnson owns 2 companies in total, including Zentalis Pharmaceuticals Inc (ZNTL) , and Aura Biosciences Inc (AURA) .
Click here to see the complete history of David Michael Johnson’s form 4 insider trades.
Insider Ownership Summary of David Michael Johnson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2023-11-10 | director |
| AURA | Aura Biosciences Inc | 2023-11-08 | director |
David Michael Johnson Latest Holdings Summary
David Michael Johnson currently owns a total of 2 stocks. Among these stocks, David Michael Johnson owns 425,339 shares of Aura Biosciences Inc (AURA) as of November 8, 2023, with a value of $4 Million and a weighting of 87.96%. David Michael Johnson also owns 144,389 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of November 10, 2023, with a value of $524,132 and a weighting of 12.04%.
Latest Holdings of David Michael Johnson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AURA | Aura Biosciences Inc | 2023-11-08 | 425,339 | 9.00 | 3,828,051 |
| ZNTL | Zentalis Pharmaceuticals Inc | 2023-11-10 | 144,389 | 3.63 | 524,132 |
Holding Weightings of David Michael Johnson
David Michael Johnson Form 4 Trading Tracker
According to the SEC Form 4 filings, David Michael Johnson has made a total of 6 transactions in Aura Biosciences Inc (AURA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Aura Biosciences Inc is the acquisition of 199,601 shares on November 8, 2023, which cost David Michael Johnson around $1 Million.
According to the SEC Form 4 filings, David Michael Johnson has made a total of 5 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the acquisition of 17,000 shares on November 10, 2023, which cost David Michael Johnson around $167,960.
Insider Trading History of David Michael Johnson
- 1
David Michael Johnson Trading Performance
GuruFocus tracks the stock performance after each of David Michael Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Michael Johnson is 9.9%. GuruFocus also compares David Michael Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Michael Johnson within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Michael Johnson's insider trading performs compared to the benchmark.
Performance of David Michael Johnson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.63 | | | | | |
| Relative Return to S&P 500(%) | 11.05 | | | | | |
David Michael Johnson Ownership Network
David Michael Johnson Owned Company Details
What does Zentalis Pharmaceuticals Inc do?
Who are the key executives at Zentalis Pharmaceuticals Inc?
David Michael Johnson is the director of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include Chief Financial Officer Melissa B, Epperly , General Counsel Andrea Paul , and Chief Medical Officer Carrie Brownstein .
Zentalis Pharmaceuticals Inc (ZNTL) Insider Trades Summary
Over the past 18 months, David Michael Johnson made 1 insider transaction in Zentalis Pharmaceuticals Inc (ZNTL) with a net purchase of 17,000. Other recent insider transactions involving Zentalis Pharmaceuticals Inc (ZNTL) include a net sale of 50,090 shares made by Cam Gallagher , a net sale of 16,724 shares made by Melissa B, Epperly , and a net sale of 10,628 shares made by Carrie Brownstein .
In summary, during the past 3 months, insiders sold 1,603 shares of Zentalis Pharmaceuticals Inc (ZNTL) in total and bought 0 shares, with a net sale of 1,603 shares. During the past 18 months, 98,364 shares of Zentalis Pharmaceuticals Inc (ZNTL) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 76,364 shares.
Zentalis Pharmaceuticals Inc (ZNTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zentalis Pharmaceuticals Inc Insider Transactions
David Michael Johnson Mailing Address
Above is the net worth, insider trading, and ownership report for David Michael Johnson. You might contact David Michael Johnson via mailing address: C/o Zentalis Pharmaceuticals, Llc, 530 Seventh Avenue, Suite 2201, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
